We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$302M
AUM Growth
+$6.74M
Cap. Flow
-$7.25M
Cap. Flow %
-2.4%
Top 10 Hldgs %
48.03%
Holding
81
New
4
Increased
36
Reduced
26
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 26.04%
2 Financials 13.65%
3 Energy 11.95%
4 Communication Services 10.49%
5 Technology 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWK icon
76
iShares MSCI Belgium ETF
EWK
$162M
-130,943
Closed -$2.47M
PACB icon
77
Pacific Biosciences
PACB
$441M
-19,500
Closed -$175K
PGEN icon
78
Precigen
PGEN
$2.36B
-8,778
Closed -$244K
UA icon
79
Under Armour Class C
UA
$2.83B
-51,831
Closed -$1.75M
VRTX icon
80
Vertex Pharmaceuticals
VRTX
$119B
-43,612
Closed -$3.8M
ETP
81
DELISTED
Energy Transfer Partners, L.P.
ETP
-7,166
Closed -$204K

Similar funds

Biondo Investment Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Biondo Investment Advisors held 81 positions worth $302M, up 2.3% from $296M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Biondo Investment Advisors's Q4 2016 filing shows 4 new, 36 increased, 26 reduced and 6 closed positions. Its largest new stake was Eagle Pharmaceuticals, Inc.: 63,575 shares worth $5.04M. The largest sale was Ford, an estimated $4.01M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 30% a quarter earlier, followed by Financials and Energy.

  • Biondo Investment Advisors's largest Q4 2016 buy was Eagle Pharmaceuticals, Inc.: 63,575 shares worth $5.04M.
  • Biondo Investment Advisors added most to Alphabet (Google) Class A in Q4 2016, an estimated $3.27M increase.
  • Biondo Investment Advisors's biggest Q4 2016 reduction was Ford, cutting an estimated $4.01M.
  • Biondo Investment Advisors fully exited Vertex Pharmaceuticals in Q4 2016, selling an estimated $3.8M.
  • Biondo Investment Advisors's ten largest holdings make up 48% of its $302M portfolio in Q4 2016.
  • Biondo Investment Advisors opened 4 new positions and closed 6 in Q4 2016.
  • Biondo Investment Advisors's portfolio value rose 2.3% quarter-over-quarter to $302M.

Based on Biondo Investment Advisors's 13F filing for Q4 2016, filed 6 Feb 2017.